RecruitingNCT06633276
Fast and Accurate Breast Cancer Diagnosis Using Nanopore Sequencing in Tanzania (Fast-ABCD Sequencing)
Nanopore Sequencing for Accelerating Breast Cancer Diagnosis in Tanzania: A Prospective Observational Study
Sponsor
University of Bonn
Enrollment
100 participants
Start Date
May 1, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
This pilot study will test the feasibility of using nanopore sequencing for breast cancer diagnosis in Tanzania. It aims to show that nanopore sequencing is non-inferior to the current standard of care, with the potential for faster and more cost-efficient results. By enhancing the speed and accuracy of diagnosis, this approach could improve treatment planning and outcomes for patients in resource-limited settings.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Patient with suspected diagnosis of breast cancer undergoing biopsy or surgical resection after specialist consultation as per institutional guidelines
- Excess fresh tumor sample
- Written informed consent
Exclusion Criteria2
- Unable to provide informed consent
- Patients who have already commenced therapy for BC (except for treatment other than biomedicine, e.g. herbal medicines)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06633276
Related Trials
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
NCT062686651 location
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
NCT053514242 locations
Neoadjuvant, SBRT With Intratumoural Pembrolizumab Followed by Neoadjuvant Chemotherapy in Breast Cancer
NCT071882462 locations
BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer
NCT048910681 location
Confocal Histolog Scanner in Routine Breast-Conserving Surgery (CHiB)
NCT069589911 location